Biocon India

揙ur ability to continuously scale new heights across the biopharmaceutical value chain enables us to realise the promise of future therapeutics.?/span> - Kiran Mazumdar-Shaw, Chairman & Managing Director Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. From discovery to development and commericalisation, we have the defining science, cost-effective drug development capabilities and significant manufacturing capacity to move ideas to market. Leveraging India抯 globally competitive cost base and exceptional scientific people resource, we are advancing our in-house R&D programs, while also providing custom and clinical research services to international pharmaceutical and biotechnology majors through our subsidiary companies, Syngene and Clinigene. Biocon has rapidly developed a robust drug pipeline, led by monoclonal antibodies and several other molecules at exciting stages in the biopharmaceutical value chain. With the successful commercial launch of our first anti-cancer drug and several promising discovery partnerships in the clinic, we remain committed to scaling new heights in frontier science and achieving new milestones in affordable medicine.